AditxtADTX -77.89% Gross Margin % is 25.00% as of Mar. 2026, which is 9515% above its 10-year median of 0.26. The stock has 4 warning signs investors should review. Among 736 Biotechnology companies, Aditxt ranks worse than 82.2% on this metric.
Gross Margin % is calculated as gross profit divided by its revenue. Aditxt's Gross Profit for the
three
months ended in Mar. 2026 was $0.00 Mil. Aditxt's Revenue for the
three
months ended in Mar. 2026 was $0.01 Mil. Therefore, Aditxt's Gross Margin % for the quarter that ended in Mar. 2026 was 25.00%.
The historical rank and industry rank for Aditxt's Gross Margin % or its related term are showing as below:
ADTX'
s Gross Margin % Range Over the Past 10 Years
Min: -367.91 Med: 0.26 Max: 25.71
Current: 21.43
During the past 9 years, the highestGross Margin % of Aditxt was 25.71%. The lowest was -367.91%. And the median was 0.26%.
ADTX's Gross Margin % is ranked worse than 82.2% of 736
companies
in the Biotechnology industry
Industry Median: 60.91
vs ADTX: 21.43
Aditxt had a gross margin of 25.00% for the quarter that ended in Mar. 2026 => Competition eroding margins
The 5-Year average Growth Rate of Gross Margin for Aditxt was 0.00% per year.
Aditxt (OTCPK:ADTX) Gross Margin % Explanation
Warren Buffett believes that firms with excellent long term economics tend to have consistently higher margins.
Durable competitive advantage creates a high Gross Margin % because of the freedom to price in excess of cost. Companies can be categorized by their Gross Margin %
1. Greater than 40% = Durable competitive advantage
2. Less than 40% = Competition eroding margins
3. Less than 20% = no sustainable competitive advantage
Consistency of Gross Margin is key
Aditxt had a gross margin of 25.00% for the quarter that ended in Mar. 2026 => Competition eroding margins
Be Aware
If a company loses its competitive advantages, usually its gross margin declines well before its sales declines. Watching Gross Margin % and Operating Margin % closely helps avoid value trap situations.
Aditxt Gross Margin % Related Terms
Aditxt Gross Margin % Historical Data
* Premium members only.
The historical data trend for Aditxt's Gross Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
ADTX vs SCPX, SIGY, RGBP: Gross Margin % Comparison
For the Biotechnology subindustry, Aditxt's Gross Margin %, along with its competitors' market caps and Gross Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Aditxt Gross Margin % vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Aditxt's Gross Margin % distribution charts can be found below:
* The bar in red indicates where Aditxt's Gross Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
A positive Gross Profit is only the first step for a company to make a net profit. The gross profit needs to be big enough to also cover related labor, equipment, rental, marketing/advertising, research and development and a lot of other costs in selling the products.
Aditxt (ADTX) has a Gross Margin % of 25.00% as of Mar. 2026. Gross margin is the ratio of total gross profit to net sales. View historical data on Aditxt and its competitors. This is 9515% above median its historical median of 0.26. According to the industry distribution chart, Aditxt ranks #605 out of 736 companies in the Biotechnology industry, placing it in the top 82.2%.
Is Aditxt's Gross Margin % too high?
Aditxt's current Gross Margin % of 25.00% is 9515% above median its 10-year median of 0.26. The Biotechnology industry median Gross Margin % is 60.91. Aditxt's value of 25.00% is 59% below this industry median. Based on the distribution chart, Aditxt ranks #605 out of 736 companies in the Biotechnology industry, which is in the bottom quartile relative to peers.
How does Aditxt's Gross Margin % compare to SCPX and SIGY?
According to the Biotechnology industry distribution chart, Aditxt ranks #605 out of 736 companies for Gross Margin %. This places Aditxt in the lower half of its industry. The industry median Gross Margin % is 60.91. Aditxt's value of 25.00% is 59% below this benchmark. While the company's 10-year median is 0.26 vs. the industry median of 60.91, Aditxt has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Gross Margin % for a Biotechnology company?
The median Gross Margin % among Biotechnology companies is 60.91, based on 736 companies in the industry. Companies in the top quartile (top 25%) have a Gross Margin % significantly above this median, while those in the bottom quartile fall well below. However, Gross Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Aditxt's current Gross Margin % of 25.00% is 59% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Gross Margin % mean?
A high Gross Margin % can signal that a stock is expensive relative to its fundamentals. Gross margin is the ratio of total gross profit to net sales. View historical data on Aditxt and its competitors. For the Biotechnology industry, the median Gross Margin % is 60.91 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Aditxt's current Gross Margin % is 25.00%, which is 9515% above median its own 10-year median of 0.26. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Aditxt stock overvalued right now?
Aditxt (ADTX) has a current Gross Margin % of 25.00%. The current Gross Margin % is 25.00%, which is 9515% above median its 10-year median of 0.26 and 59% below the Biotechnology industry median of 60.91. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Gross Margin % calculated?
Gross Margin % is calculated from a company's financial statements. For Aditxt (ADTX), the current Gross Margin % is 25.00% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Aditxt Inc is a life sciences company that develops, builds, and grows innovations with a focus on monitoring and modulating the immune system. It develops products designed to induce tolerance to transplanted organs. Its portfolio consists of two programs Adimune and AditxtScore. It firm's immunosuppressive (anti-rejection) drugs have made possible life-saving organ transplantation procedures and blocking of unwanted immune responses in autoimmune diseases. It is also developing a technology called Apoptotic DNA Immunotherapy (ADi) ADI-100, which utilizes a novel approach that mimics, the way bodies naturally induce tolerance to tissues. The company operates in one segment, which is focused on the discovery and development of biopharmaceutical products.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ADTX has been successfully added to your 